Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001771653-20-000001
Filing Date
2020-01-02
Accepted
2020-01-02 14:02:16
Documents
1
Effectiveness Date
2020-01-02
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 7273
  Complete submission text file 0001771653-20-000001.txt   8297
Mailing Address 953 INDIANA STREET SAN FRANCISCO CA 94107
Business Address 953 INDIANA STREET SAN FRANCISCO CA 94107 415-885-7810
Alessa Therapeutics, Inc. (Filer) CIK: 0001771653 (see all company filings)

EIN.: 830762950 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-356944 | Film No.: 20501016